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Abstract
Golden Rice has been genetically modiﬁed to produce beta-carotene in the endosperm of
grain. It could improve the vitamin A status of deﬁcient food consumers, especially women
and children in developing countries. This paper analyses potential impacts in a Philippine
context. Since the technology is still at the stage of R&D, beneﬁts are simulated with a scen-
ario approach. Health eﬀects are quantiﬁed using the methodology of disability-adjusted life
years (DALYs). Golden Rice will not completely eliminate the problems of vitamin A
deﬁciency, such as blindness or increased mortality. Therefore, it should be seen as a comp-
lement rather than a substitute for alternative micronutrient interventions. Yet the tech-
nology could bring about signiﬁcant beneﬁts. Depending on the underlying assumptions,
annual health improvements are worth between US$ 16 and 88 million, and rates of return
on R&D investments range between 66% and 133%. Due to the uncertainty related to key
parameters, these results should be treated as preliminary.
# 2004 Elsevier Ltd. All rights reserved.
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Introduction
VitaminA deﬁcien cy (VAD) is a major problem inlarge parts of the developin g
world. An estimated 250,000–500,000 VA-deﬁcient children go blind every year
(West and Darnton-Hill, 2001). Apart from acute eye symptoms, VAD also weak-
ens the immune system, thus increasing the incidence and severity of infectious
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doi:10.1016/j.foodpol.2004.03.001diseases. For adults, the implications can be serious too, especially for pregnant
and lactating women. Nearly 600,000 women die from childbirth-related causes
each year, many of them from complications which could be reduced through bet-
ter provisionof vitaminA ( Sommer and West, 1996). The most aﬀected are the
poor, whose diets are predominated by less nutritious staple foods on account of
lacking purchasing power and limited awareness.
During the last decade, a lot of eﬀorts have been made to reduce VAD in devel-
oping countries. Food fortiﬁcation, supplementation and dietary education pro-
grammes have been undertaken. A complementary approach is to enrich major
staple foods with beta-carotene through plant breeding. For some crop species,
such as maize and sweet potato, cultivars with high beta-carotene contents have
been identiﬁed, which can be used in traditional breeding programmes. However,
beta-carotene does not occur naturally in the endosperm of rice—the major staple
food in large parts of Asia. Hence, for rice, use of biotechnology is required
(Bouis, 2000). Recently, so-called Golden Rice (GR) has been developed through
genetic engineering at Swiss and German universities (Ye et al., 2000). Three gene
constructs were inserted into the rice genome, which complete the biochemical
pathway needed for beta-carotene production in the grain. Although GR is still at
the stage of research and development (R&D), it is already surrounded by a lot of
public controversy. Some optimists praise it as the solution to overcome malnu-
trition and VAD. Others denounce it as a mere child of the biotech lobby and con-
sider it a useless and rather harmful innovation for the poor.
The aim of this study is to analyse the potential beneﬁts of GR in the
Philippines. VAD constitutes a serious problem there. Moreover, in 2001, GR tech-
nology was transferred to the Philippine-based International Rice Research Insti-
tute (IRRI), where adaptive research is now being carried out. Scientists are
currently working on verifying and improving the gene constructs and incorporat-
ing them into popular indica varieties. After that, a testing phase will follow. GR
could become commercially available in2007.
Giventhat actual impacts are n ot observable at this stage, the study takes anex
ante perspective. Since the main eﬀect will be an improvement in the health and
nutrition status of rice consumers, the methodological challenge is to appropriately
combine issues of agricultural, nutrition and health economics. At ﬁrst, an analyti-
cal framework is developed to conceptualise the research and identify key issues
that might inﬂuence the innovation’s impact. Then, health problems associated
with VAD in the Philippines are described and classiﬁed. Resulting costs are quan-
tiﬁed using the methodology of disability-adjusted life years (DALYs). These costs
are expressed inDALYs lost. Ina further step, DALYs to be gain ed through GR
are calculated, and a preliminary cost–beneﬁt analysis is provided. This is among
the ﬁrst studies to quantify the health beneﬁts from micronutrient-enriched crops.
1
1 Based on detailed food intake data from one region in the Philippines, Dawe et al. (2002) analysed
the role that GR could play for the VA supply of children. However, they did not explicitly consider the
health eﬀects and economic beneﬁts resulting from an improvement in VA status.
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framework. Therefore, the calculations build on scenarios and assumptions. To use
the best information available at this stage, assumptions are based on interviews
with local and international plant researchers, nutritionists and health experts. A
sensitivity analysis suggests that the exact numerical results should be interpreted
with some caution. Nonetheless, the study might help rationalise the controversy
surrounding GR technology. More generally, it will contribute to a better under-
standing of the ramiﬁcations of food crops with enhanced nutritive values in devel-
oping countries. The breeding approach is increasingly seen as a powerful tool to
ﬁght micronutrient deﬁciencies (CIAT/IFPRI, 2002), but empirical evidence is still
lacking.
Analytical framework
Conceptual issues
New crop technologies are usually evaluated by looking at productivity eﬀects in
agricultural production. Aggregate beneﬁts can then be calculated by modelling a
shift inthe commodity supply curve. This approach, however, is on ly suitable
when the technology involves improved agronomic traits. Technologies that
enhance the quality of commodities are rather associated with beneﬁts at the level
of consumption. The primary goal of GR is to improve the health and nutrition
status of rice consumers. Generally, quality improvements would increase the con-
sumers’ willingness to pay, entailing an upward shift in the demand curve. But this
presupposes that consumers recognise and appreciate the quality improvement.
Awareness of VAD is generally low among the poor. Moreover, due to limited
purchasing power, nutritional needs are often not translated into eﬀective market
demand. Capturing the beneﬁts of GR in a market model is therefore not appro-
priate. Instead, the technology’s positive health eﬀects have to be identiﬁed and
measured.
As Fig. 1 illustrates, the impact will mainly depend on two factors: (i) the tech-
nology’s eﬃcacy and (ii) its coverage rate. The eﬃcacy of GR is deﬁned as the
capacity to improve the health status of a VA-deﬁcient individual. This is inﬂu-
enced inter alia by the beta-carotene content in the grain and its bioconversion to
VA in the human body. Coverage, on the other hand, is deﬁned as the fraction of
the populationactually eatin g GR. This is a fun ctionof techn ology accessibility
and producer and consumer acceptance. To some extent, these factors can still be
inﬂuenced through adaptive research. But there are also exogenous variables which
are harder to control.
Methodology
We quantify health costs of VAD and beneﬁts of GR using the methodology of
DALYs. This approach was developed by Murray and Lopez (1996), and is pro-
mulgated by the World Health Organisation (WHO) and the World Bank as a
means of combining information about mortality and morbidity within a single
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previously for the evaluationof agricultural techn ologies.
The general formula suggested by Murray and Lopez (1996) was adapted to our
context, so that the total number of DALYs lost through VAD is deﬁned as
DALYsLost ¼ YLL þ YLDtemp þ YLDperm ð1Þ
where YLL is the number of life years lost due to mortality, and YLDtemp and
YLDperm are years of life with temporary and permanent disability, respectively.
We concentrate on three target groups—children under the age of seven, pregnant
women and lactating women. Furthermore, diﬀerent disease levels resulting from
VAD are taken into account. DALYs lost are calculated on an annual basis. Only
deaths and new cases of disease occurring in the reference period are considered,
whereby health costs are accumulated over the duration of particular conditions.
Thus, we canwrite
DALYsLost ¼
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Fig. 1. Factors inﬂuencing the impact of Golden Rice.
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associated with VAD, and Lj is the average remaining life expectancy. Iij is the inci-
dence rate of temporary disease i, Dij is the corresponding disability weight, and dij
is the durationof the disease. Ikj is the incidence rate of permanent disease k, while
r is the rate at which future costs are discounted. As is standard in DALY calcula-
tions (World Bank, 1993), we use a discount rate of 3%. Unlike Murray and Lopez
(1996), we do not include an age-weighting function, because children are among
the most aﬀected by VAD. Age-weighting is controversial on equity grounds
(Anand and Hanson, 1998), and Mathers et al. (1999) showed that it does not sig-
niﬁcantly change the results in many cases.
The number of DALYs lost through VAD is calculated with and without GR,
and the diﬀerence is interpreted as the technology’s impact. Without GR is the situ-
ation in the Philippines today, so we use existing epidemiological data. Health pro-
blems will be reduced if people start eating GR on a regular basis. To derive the
expected reduction in incidence rates, we build on a model adapted from Brenzel
(1993):
Inew
ij ¼ 1  ð EjCÞ
  
Iij: ð3Þ
The new incidence rate of disease i ingroup j (Inew
ij ) is a function of the group-
speciﬁc eﬃcacy rate of GR (Ej), and the technology’s coverage rate (C). Changes in
the incidence of permanent diseases and mortality rates are calculated accordingly.
Eﬃcacy and coverage were already introduced conceptually in Fig. 1. These two
variables will be further discussed and speciﬁed in later sections.
DALYs are expressed inyears of ‘‘healthy’’ life lost, which is a han dy measure
for the comparison of diseases or health interventions. For a cost–beneﬁt analy-
sis, however, a monetary value is needed, so that a dollar amount can be attrib-
uted to each DALY lost. The value should be adjusted to the living standard in
a particular context. One possibility is to take the per capita income, albeit in
developed countries much higher values are often imputed (Tolley et al., 1994).
For the Philippines, we use the annual per capita income of US$1030 (NSCB,
2000). This is just a convenient device for economic analysis, not an attempt to
quantify the intrinsic value of life. The latter would certainly entail serious ethical
concerns.
Vitamin A deﬁciency and related diseases
In order to assess the costs of VAD and the potential impact of GR, it is essen-
tial to understand the linkages between nutrition, VA status and health. VA is a
fat-soluble vitamin. It occurs in two forms, the active (preformed) and the precur-
sor form. The most frequent active form is retinol, which can only be synthesised
in animals and humans. Precursor forms, also known as carotenoids, are common
in many fruits and vegetables. The most well-known carotenoid is beta-carotene,
which the humanbody cancon vert to retin ol. WhenVA supply is lower thanthe
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chronic health impairments.
2
VAD is subdivided into two categories: sub-clinical and clinical VAD. Sub-clini-
cal VAD is usually not associated with immediate symptoms. But—as VA plays an
important role in maintaining immune competence—it can cause high morbidity
and mortality, especially among children. Occurrence of measles, diarrhea and
other infectious diseases, as well as case fatalities from these conditions, are signiﬁ-
cantly higher in VA-deﬁcient groups than in populations with normal VA status
(Underwood, 1998). A link has also been established between VAD and maternal
survival up to two years following delivery (WHO, 2002; West and Darnton-Hill,
2001). Clinical VAD involves the characteristic ocular manifestations, usually
referred to as ‘‘xerophthalmia’’. Xerophthalmia canbe subdivided in to the follow-
ing levels according to degree of VAD and medical severity (WHO, 1982): (i) night
blindness (XN), (ii) Bitot’s spot (X1B), (iii) corneal ulceration (X2, X3A, X3B),
and (iv) corneal scars (XS).
Night blindness is the earliest clinical manifestation and is associated with the
inability to see in dim light. Bitot’s spots are irregular shaped foam-plaques onthe
underside of the eyelid. Often, they are associated with a dryness of the white of
the eye. Night blindness and Bitot’s spot can develop into more severe manifesta-
tions when not medicated. When treated with high-potency VA, however, the eye
usually fully recovers withina matter of weeks. Corneal ulceration and corneal
scars indicate destruction of a part or all of the cornea, the outermost layer of the
eye. While with immediate VA treatment, corneal xerophthalmia can heal with
only minimal structural damage, it can rapidly lead to irreversible blindness when
not treated on time (Sommer and West, 1996).
These four levels of xerophthalmia are included as temporary diseases in this
study, whereas blindness is the only permanent disease. VAD-related mortality is
considered independent of eye symptoms, because it can already occur at sub-clini-
cal deﬁciency levels. Temporal disabilities associated with infectious diseases from
which individuals recover later on are neglected. This leads to an underestimation
of total health costs. But, as non-fatal infectious diseases are usually of short dur-
ation, the resulting inaccuracy will be rather small.
Vitamin A deﬁciency in the Philippines
Nutrition situation
In the Philippines, the Food and Nutrition Research Institute (FNRI) carries out
nutrition and health surveys every ﬁve years. Nutrition data are based on actual
2 The RDA is the average daily dietary intake level that is suﬃcient to meet the nutrient requirements
of healthy individuals in a particular life stage and gender group (IOM, 2002). It has beenestablished to
give approximately three months of body stores, so that temporary undersupply can be compensated.
However, insuﬃcient VA intake over an extended period of time will lead to a depletion of body stores.
When determining the average age of onset of health impairments, we take into account such delays.
R.Zimmermann, M.Qaim / Food Policy 29 (2004) 147–168 152food intake. The typical Filipino diet is rice, boiled ﬁsh or meat and relatively little
vegetables. On average, this diet only meets 88% of the RDA for energy, and even
less for other nutrients. Vulnerable groups, such as pre-school children and preg-
nant and lactating women, usually achieve less than 70% of their energy require-
ments (FNRI, 1993, 1998).
Micronutrient deﬁciencies are widespread too. In addition to iron and iodine
deﬁciencies, VAD is considered a major health problem, with prevalence rates
exceeding the WHO cut-oﬀ points. Since the early 1990s, the government has been
implementing and encouraging diﬀerent public interventions. Initiatives include the
distribution of VA capsules and the fortiﬁcation of margarine and other processed
food items. Such interventions are successful in improving the VA status of the
population, but coverage rates are incomplete (Fiedler et al., 2000).
DALYs lost
Using the methodology described above, the annual costs of VAD in the
Philippines are calculated in the following. We take the late 1990s as the reference
period. Prevalence rates for diﬀerent levels of VAD and associated diseases were
taken from FNRI survey data. Unfortunately, the most recent survey of 1998 only
looked into sub-clinical levels of VAD, so we use 1993 data for the prevalence of
clinical manifestations. Based on sub-clinical VAD alone, prevalence rates were
slightly higher in1998 thanin1993 for all three target groups, but otherwise quite
similar. Hence, a combination of data from both surveys should be in order. The
prevalence rates used in this study are shown in Table 1. Missing values were
replaced by estimates of local epidemiologists.
Eq. (2) above indicated that the DALY calculations should be based on inci-
dence rather than prevalence rates. However, incidence rates of particular diseases
are rarely available in health statistics. Diﬀerent authors suggested that, when using
prevalence instead of incidence rates, the duration of diseases should be taken as
one year, in order to avoid inﬂation of annual health costs (e.g., Brenzel, 1993;
Murray and Lopez, 1996). We follow this approach for temporary diseases. For
blindness, neither prevalence nor incidence rates are available in Philippine stat-
istics. Yet VAD-related blindness is always preceded by corneal xerophthalmia.
Approximately, half of all corneal cases lead to blindness within a short period of
time (West and Darnton-Hill, 2001). Therefore, the incidence rate of blindness is
around 50% of the combined prevalence rates of corneal ulceration and corneal
scars.
Especially breast-fed infants have body stores of VA, which have to be depleted
before eye symptoms emerge (Newman, 1993). The incidence of corneal xeroph-
thalmia usually peaks at two to three years of age (West and Darnton-Hill, 2001).
Hence, we assume that the average age of onset of blindness among children is 2.5.
For pregnant and lactating women, the average age of onset is assumed to be 30.
This is beyond the midpoint of their reproductive life, which is plausible consider-
ing a gradual exhaustion of body stores with repeated pregnancies. Disability
weights for temporary and permanent diseases were speciﬁed together with health
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Bitot’s spot, it is 0.25, and for corneal ulceration, corneal scars and blindness, it is
0.5—equal across the three target groups.
3 These weights are consistent with values
that were used inother studies ina similar con text (e.g., World Bank, 1994).
Sub-clinical levels of VAD have a disability weight of zero, because there are no
immediate symptoms. However, health costs of related infectious diseases are cap-
tured in the form of increased mortality rates. In countries where micronutrient
malnutrition presents a moderate risk for the population, at least 3% of all infant
deaths, and 10% of all deaths among pre-school children, are attributable to VAD
(World Bank, 1993). Although in high-risk countries, the proportions can be much
higher (Sommer and West, 1996), we use these ﬁgures for the Philippines as cau-
tious assumptions. According to our interviews with local experts, about 6% of all
maternal deaths during pregnancy and delivery, and 4% of all deaths during lac-
tation, could be prevented through a better provision of VA.
The results of the DALY calculations without GR are shown in Table 2.I n
total, VAD causes an annual loss of about 270,000 years of ‘‘healthy’’ life in the
Philippines. The highest cost occurs among children. Losses due to mortality are
much higher inthis group thaninthe other two groups, which un derlin es that
blindness and visual problems constitute only part of the overall burden. Also, the
total number of children aﬀected by xerophthalmia is higher than the number of
Table 1
Prevalence rates and number of people aﬀected by VAD
Children( <7 years) Pregnant women Lactating women
Prevalence
rate (%)
Number of
aﬀected
a
(thousand)
Prevalence
rate (%)
Number of
aﬀected
a
(thousand)
Prevalence
rate (%)
Number of
aﬀected
a
(thousand)
Sub-clinical
VAD
38.00
b 5082.81 22.20
b 359.23 16.50
b 260.36
Night blind-
ness
0.40
c 53.50 0.60
c 9.71 0.90
c 14.20
Bitot’s spot 0.10
c 13.38 0.40
d 6.47 0.70
d 11.05
Corneal ulcer-
ation
0.05
d 6.69 0.30
d 4.85 0.50
d 7.89
Corneal scars 0.00
c 0.00 0.15
d 2.43 0.30
c 4.73
Blindness 0.03
e 3.34 0.23
e 3.64 0.40
e 6.31
a Derived by multiplying prevalence rates with the total number of people in each group (NSCB,
2000).
b Based on FNRI (1998).
c Based on FNRI (1993).
d Based onexpert estimates.
e These are incidence rates, derived as 50% of the combined prevalence rates of corneal xerophthalmia.
3 Blindness can be monocular, for which the disability weight might be lower, or binocular, for which
the weight might be higher. Since available statistics do not diﬀerentiate, we assume an average value.
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womenexceed those for childrenbecause of higher prevalen ce rates for corn eal
ulceration and corneal scars. In fact, the incidence of blindness among Filipino
childrenis lower thaninother coun tries of South an d Southeast Asia, which might
partly be due to the country’s VA supplementation programme. Converting the
total DALYs in Table 2 into monetary terms, we result in a loss of about $278 mil-
lion per year. This is equivalent to 0.3% of the Philippine gross national product
(GNP).
Eﬃcacy of Golden Rice
The maineﬀect of GR will be to reduce the prevalen ce of VAD. Eq. (3) showed
that this is a function of the technology’s eﬃcacy and coverage. This section
explains the factors inﬂuencing eﬃcacy, while the next discusses issues of coverage.
Because exact parameter values are unknown, we use two scenarios for calculating
the potential impact of GR: one more pessimistic scenario and another which is
rather optimistic. Parameter variations beyond these assumptions are tested later
onina sen sitivity an alysis.
Amount of beta-carotene
The current amount of beta-carotene that researchers managed to get into GR is
1.6 lg/g. Ye et al. (2000) argued that the same technology could yield 2.0 lg, if a
homogenous line with uniformly coloured grains were produced. With slight mod-
iﬁcations in the gene constructs, such as using more eﬃcient promoters, the
amount could be further increased. According to Datta (2001), it could be possible
to achieve 3.0 lg withinthe adaptive research phase. Evenhigher amoun ts are the-
oretically possible, but they could potentially have undesirable eﬀects on agricul-
tural yields or taste. In the pessimistic scenario, we assume a beta-carotene content
of 1.6 lg/g, whereas inthe optimistic scen ario, we assume 3.0 lg/g.
Post-harvest treatment, storage and processing of GR might also inﬂuence its
beta-carotene content at the time of consumption. For leafy vegetables, it has been
reported that exposure to sunlight after harvesting can result in a considerable loss
of beta-carotene (Boileau et al., 1998). The same study found that losses are negli-
gible for carrots, which is probably due to their more compact structure and
smaller surface area. Giventhese results, it is likely that post-harvest losses of beta-
carotene in GR can be kept relatively low. Still, some losses might occur with
Table 2
DALYs lost due to VAD without GoldenRice
Children Pregnant women Lactating women Total
Loss due to mortality 80,040 2235 1424 83,700
Loss due to disability 59,478 46,590 80,335 186,403
Total loss 139,518 48,826 81,760 270,103
Inmon etary terms (millionUS$) 143.7 50.3 84.2 278.2
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often reduces the bioavailable portion of beta-carotene, while cooking at tempera-
tures up to 100
vC canevenin crease the extractable amoun t of caroten oids ( Dietz
et al., 1988). Inthe Philippin es, rice is usually steamed at temperatures below the
boiling point, so that processing might not lead to signiﬁcant additional losses. It is
assumed that total post-harvest losses are 25% inthe pessimistic, while they are
zero inthe optimistic scen ario.
Bioconversion
Bioconversion is deﬁned as the process of beta-carotene absorption by the
human body and its transformation to retinol. After absorption, transformation
takes place with a factor of approximately 2:1. However, variationinterms of
absorbability occurs between diﬀerent types of food. Absorption is most eﬃcient
when physiological amounts of beta-carotene are dissolved in oil. For spinach, an
absorption eﬃciency of only 7% has been reported (Castenmiller et al., 1999).
Other authors reported values of 11–12% for broccoli, and of 18–26% for carrots
(Micozzi et al., 1992; To ¨rro ¨nen et al., 1996). Ina study with school childrenin
Indonesia, de Pee et al. (1998) found that the VA activity of beta-carotene in fruits
and yellow tubers was more than double the activity of the same carotenoid in
dark-green leafy vegetables. Generally, absorbability depends on the state of beta-
carotene and its association with plant matrix materials in the food source. Also, it
is correlated with the intake of complimentary ingredients in the diet. Low fat con-
sumption reduces the absorption of beta-carotene signiﬁcantly.
Using these recent ﬁndings, IOM (2002) estimated the retinol equivalency ratio
for beta-carotene from food in a mixed diet, which includes fruits and vegetables,
to be 12:1.
4 For GR, feeding tests will only be carried out over the next few years,
so that speciﬁc data and information are not available. We take the 12:1 bio-
conversion rate as our pessimistic assumption. However, since rice has a simple
food matrix with totally digestible carbohydrates, beta-carotene absorption might
be higher than when obtained from fruits and vegetables (cf. Underwood, 2000).
As part of a balanced diet, the retinol equivalency ratio could even be as high as
for beta-carotene dissolved in oil, that is, 2:1 (Russell, 2002). Yet this is the absol-
ute upper bound, which might not be reached under normal conditions in the
Philippines. Especially among the poor, the low fat content in the diet could con-
strain beta-carotene absorption. Therefore, we use a more cautious bioconversion
rate of 6:1 inthe optimistic scen ario.
Eﬃcacy model
Once beta-carotene has been absorbed and converted to retinol, the human body
canuse it for physiological purposes. For the treatmen t of acute cases of xeroph-
4 This is only half the value of 6:1, which was assumed for a long time in the nutrition community. The
established assumption was mainly challenged through the work of de Pee et al. (1998) in Indonesia.
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high-potency VA are administered (Sommer, 1995). However, GR is meant as a
daily source of beta-carotene that helps prevent health problems and improve the
overall VA status of the population. Therefore, therapeutic threshold models are
inappropriate in this context.
Bauernfeind (1980), Olson (1994) and Underwood (1998) describe the relation-
ship between regular VA supply and the occurrence of health problems as a con-
tinuous, logarithmic function. That is, incremental supply leads to a steady
improvement in health status, whereby the response is more pronounced at higher
levels of deﬁciency. This relationship is shown in Fig. 2. VA supply (x) is depicted
onthe horizon tal axis, whereas disease levels (DL) are shownonthe vertical axis.
Current VA supply (CVA) is below the RDA, a situation which we actually
observe for the target groups inthe Philippin es. Improved VA supply (IVA) repre-
sents current supply plus the increment from GR consumption. This level might
still be lower thanthe RDA. However, the lower the in itial supply, the higher is
the technology’s positive health eﬀect. Beyond the point of RDA, no further
improvement is possible.
5 Without having to specify units of measurement for DL,
eﬃcacy (E) canbe calculated as the ratio of two areas, n amely area A divided by
Fig. 2. Relationship between VA supply and disease levels.
5 Although excessive intake of preformed VA can be toxic, negative health eﬀects are not known for
over-supply of beta-carotene; unneeded amounts are excreted without conversion to retinol (Sommer
and West, 1996).
157 R.Zimmermann, M.Qaim / Food Policy 29 (2004) 147–168area A þ B. Thus, E can take any value between zero and one, whereby it is posi-
tively correlated with the convexity of the curve.
Although this general relationship is widely accepted in the literature, concrete
evidence on the exact numerical association between VA supply and diﬀerent dis-
ease levels is lacking (Underwood, 1998; Sommer and West, 1996). This makes
parameterizationof the fun ctiondiﬃcult. We use the followin g rectan gular hyper-
bola, which has a moderate curvature and fulﬁls the condition of a zero point at
x ¼ RDA:
DLðxÞ¼
1
x
 
1
RDA
: ð4Þ
Other speciﬁcations are theoretically possible. We will return to this issue in the
sensitivity analysis. Using Eq. (4), E canbe calculated as:
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dx
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FNRI (1993) provides food intake data separately for the three target groups. This
is the most recent nationally representative data available that takes into account
intra-household distribution. Rice is the dominant staple, providing about half of the
daily calorie consumption for children, and slightly more for pregnant and lactating
women. While micronutrient deﬁciencies are more pronounced in poorer households,
diﬀerences in rice intake are relatively small across income levels. For instance, aver-
age daily rice consumption for lactating women is 252 and 277 g in the poorest and
richest households, respectively. Lactating women in medium-income households
consume around 300 g. There are more pronounced geographical diﬀerences how-
ever. Rice intake is above average in the northern Philippines, whereas more corn is
eaten in parts of Visayas and Mindanao. We use average national data for the three
target groups, because the available epidemiological information does not allow dis-
aggregation by income or region. Within the group of children, the average rice
intake exaggerates the amount for infants below one year of age. But breast-fed
infants beneﬁt from the better VA supply of their mothers (Newman, 1993), and
VAD-related health problems only peak at two to three years of age.
Details and results of the eﬃcacy calculations are presented in Table 3. Inthe
optimistic scenario, eﬃcacy is much higher than in the pessimistic one. Given the
higher assumptions on beta-carotene content and bioconversion, this should not
surprise. Noteworthy, however, is that eveninthe optimistic scen ario, eﬃcacy is
signiﬁcantly lower than 100% for all target groups. This means that GR alone will
not eliminate VAD and associated health problems.
6 Nonetheless, its potential to
improve the VA and health status of the Philippine population is considerable.
6 Although Dawe et al. (2002) use a diﬀerent approach and do not derive a clinical eﬃcacy of GR,
their results on technology contribution to VA requirements are similar to ours.
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Accessibility
Access to GR by consumers will primarily depend on the extent to which the
new rice varieties will be used in agricultural production, and, hence, their avail-
ability on local food markets and for home consumption. The ﬁrst precondition is
that the technology will be commercially approved under the bio- and food safety
regulations. Although the biotechnology debate in the Philippines has been contro-
versial in the last few years, the National Committee on Biosafety recently
approved commercial cultivationof gen etically modiﬁed corn . We take this as an
indication that biosafety procedures for GR will be handled eﬃciently by national
authorities, once the technology enters the testing phase.
Currently, researchers are incorporating GR technology into high-yielding vari-
eties that are already established inthe market, are con sumed by the poor an d are
easily crossable with other breeding lines. These modiﬁed varieties will be handed
over to farmers free of charge.
7 They canbe reproduced by the growers themselves,
so that there could potentially be a speedy dissemination through a farmer-to-
farmer exchange of seeds. Experience from the green revolution shows that accept-
able germplasm candiﬀuse very rapidly inthe coun try ( Hayami and Kikuchi,
2000). Thus, also subsistence rice farmers and poor consumers in remote rural
Table 3
VitaminA supply an d eﬃcacy of GoldenRice
Pessimistic scenario Optimistic scenario
Children Pregnant
women
Lactating
women
Children Pregnant
women
Lactating
women
Rice intake (g/day)
a 121.00 245.00 274.00 121.00 245.00 274.00
Current VA supply from all
food sources (lg/day)
a
234.30 597.10 404.10 234.30 597.10 404.10
RDA for VA (lg/day)
b 500.00 800.00 1250.00 500.00 800.00 1250.00
VA deﬁcit (lg/day) 265.70 202.90 845.90 265.70 202.90 845.90
Beta-carotene intake through
GR (lg/day)
145.20 294.00 328.80 363.00 735.00 822.00
VA from GR after
bioconversion (lg)
12.10 24.50 27.40 60.50 122.50 137.00
Improved VA supply (lg/day) 246.40 621.60 431.50 294.80 719.60 541.10
Contribution of GR
to reduce VA deﬁcit (%)
4.55 12.07 3.24 22.77 60.37 16.20
Eﬃcacy (%) 11.54 24.64 9.65 47.97 86.08 40.30
a These ﬁgures are based on FNRI (1993).
b These ﬁgures represent internationally used RDAs (IOM, 2002).
7 Private companies, holding patents over certain technology components, agreed to waive royalty
payments when GR is used by resource-poor producers. Most of the rice in the Philippines is produced
by small-scale, semi-subsistence farmers.
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other VA intervention programmes.
Acceptance
Technology acceptance depends on attitudes towards biotechnology in general
and features of GR in particular. Although biotechnology opposition in the
Philippines was fairly strong in the past, there are indications that public attitudes
are gradually becoming more positive. With respect to acceptability of GR itself,
very little is known so far. Only its yellowish colour has often been named as a poss-
ible constraint. Most of the rice consumed in the Philippines is polished and white.
In order to get a better understanding of acceptance issues, we carried out focus
group discussions with rice producers and consumers in two typical rice villages in
Laguna and Nueva Ecija provinces. Although participants were not representative
of the Philippine population, the discussions revealed some interesting perceptions.
Consumers were generally interested in obtaining VA-enriched rice, and they did
not express reservations about the yellow colour of the grain. Their responses
revealed, however, that changes in taste and price would restrict widespread use of
GR. Rice farmers, on the other hand, were concerned about the fertility of har-
vested seeds. Yields will also be an important adoption factor: given that poor con-
sumers are not willing to pay more for VA-enriched rice, a technology-related
productivity loss would not be compensated by a market price premium.
Although IRRI researchers do not expect changes in taste and agronomic char-
acteristics, related tests have not been conducted yet. Hence, undesirable eﬀects
cannot be ruled out with certainty. Furthermore, experience in diﬀerent countries
with adoption of other value-enhanced crops, such as quality protein maize, shows
that education and information can be crucial determinants (Lauderdale, 2000).
The transgenic approach has the advantage that GR technology can also be incor-
porated into newly bred varieties with superior agronomic traits, to increase adop-
tion incentives for farmers. Nonetheless, the yellow colour requires explanation, so
that public information campaigns will be essential for widespread use. Based on
the limited information available thus far, it is extremely diﬃcult to assess the
future coverage of GR. The variable is not completely random however; research-
ers and policymakers can inﬂuence its outcome. For the pessimistic scenario, we
assume that 40% of the consumers would switch to GR, while in the optimistic
scenario, the coverage rate is 60%. Initially, consumers are likely to test GR in
smaller quantities, but it is supposed that the whole rice intake, as shown in
Table 3, will be substituted eventually. Diﬀerent assumptions of coverage rates will
be tested in the sensitivity analysis.
Potential beneﬁts of Golden Rice
Based on the discussion in previous sections, we now turn to the evaluation of
potential beneﬁts of GR for the pessimistic and optimistic scenarios. For easy ref-
erence, the underlying assumptions are summarised in the following.
R.Zimmermann, M.Qaim / Food Policy 29 (2004) 147–168 160. Pessimistic scenario. The amount of beta-carotene is 1.6 lg/g of GR. Post-har-
vest losses are 25%. The bioconversion rate to VA is 12:1, and the technology
coverage rate is 40%.
. Optimistic scenario. The amount of beta-carotene is 3.0 lg/g of GR. There are
no signiﬁcant post-harvest losses. The bioconversion rate is 6:1, and the tech-
nology coverage rate is 60%.
DALYs gained
Using the assumed values for the technology’s eﬃcacy and coverage, new preva-
lence and mortality rates were derived, and the remaining number of DALYs lost
with GR was calculated. The diﬀerence between these values and DALYs lost
without GR is the projected annual beneﬁt, expressed in years of ‘‘healthy’’ life
gained. The results are shown in Table 4.
The total gaininthe pessimistic scen ario is about 15,000 DALYs, while inthe
optimistic scenario it is about 85,000 DALYs. Compared to the situation without
GR (see Table 2), the health burdenis reduced by 5.7% an d 31.5%, respectively.
Although the biggest overall beneﬁts accrue for the group of children, the gains
resulting from reduced disability are higher for pregnant and lactating women.
This is due to the lower initial prevalence of corneal xerophthalmia among children
in the Philippines. For them, the gains due to reduced mortality are more impor-
tant. After depletion of body stores, even moderate levels of deﬁciency can have
fatal consequences, so that an improvement in the VA status can lower the death
toll signiﬁcantly. While in the pessimistic scenario, GR can avert 136 child deaths
per year, in the optimistic scenario, the number of averted cases is 798. Table 4
also shows DALYs gained in monetary terms. In spite of the comparatively low
value of $1030 per DALY, the annual beneﬁts are sizeable.
Table 4
Potential annual beneﬁts of Golden Rice (DALYs gained)
Children Pregnant
women
Lactating
women
Total
Pessimistic scenario
Gaindue to reduced mortality 3929 234 58 4221
Gaindue to reduced disability 2920 4872 3298 11,090
Total gain 6849 5106 3357 15,311
Inmon etary terms (millionUS$) 7.1 5.3 3.5 15.8
Optimistic scenario
Gaindue to reduced mortality 23,035 1155 344 24,534
Gaindue to reduced disability 17,118 24,062 19,423 60,602
Total gain 40,153 25,217 19,767 85,137
Inmon etary terms (millionUS$) 41.4 26.0 20.4 87.7
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This sub-sectionputs the an ticipated mon etary ben eﬁts of GR inrelationto
R&D investments. The project was started in 1992, with the ﬁrst phase at Swiss
and German universities focusing on basic scientiﬁc principles. The concept was
successfully provenin1999 ( Ye et al., 2000). Research expenditures during this
phase in Europe were estimated at $3 million. These costs are not considered in
our analysis in the Philippines, because the knowledge and technology generated
are likely to produce much wider international beneﬁts.
A breakdown of the estimated cost of R&D at IRRI and technology testing and
dissemin ationinthe Philippin es is givenin Table 5. The three-year adaptive
research phase includes the veriﬁcation and improvement of available gene con-
structs and their incorporation into popular varieties. After this, a three-year test-
ing phase is foreseen for ﬁeld trials, feeding experiments and bio- and food safety
evaluation. The budget also includes outlays for variety registration and commer-
cialisation. The total cost for the six years of R&D and testing is estimated at
around $3.7 million. IRRI has an international mandate, and the GR varieties will
also be transferred to a number of other countries. Nonetheless, we consider the
full costs in the Philippine context. Furthermore, it is reckoned that expenditures
of about $7 million will be necessary after the testing phase for a broad infor-
mation and dissemination campaign, including the ﬁrst delivery of seeds to farm-
ers. This value is based ona detailed cost estimate of promotion al activities for the
VA supplementation programme (Fiedler et al., 2000).
8 After commercial release of
GR varieties, a recurrent annual cost of $0.5 million is assumed for germplasm
maintenance and monitoring.
Returns on project investments were calculated, assuming a beneﬁt stream of 10
years after technology release. In the pessimistic scenario, the internal rate of
return (IRR) is 66%, while it is 133% in the optimistic one. Notwithstanding the
low monetary value imputed per DALY gained, these ﬁgures are relatively high
when compared to R&D projects focusing on improvements of agronomic traits in
agricultural crops. This preliminary cost–beneﬁt analysis conﬁrms that breeding for
micronutrient-dense staple foods can be an investment with high social returns.
It would certainly be interesting to compare these results for GR with other
alternatives to reduce VAD. Unfortunately, cost–beneﬁt studies for VA interven-
tions in the Philippines or other countries are not available. Fiedler et al. (2000)
carried out a cost-eﬀectiveness analysis for the Philippines’s supplementation and
fortiﬁcationprogrammes. But, as is commonincost-eﬀectiven ess studies of
nutrition interventions, their measure of eﬀectiveness is the number of people being
lifted from deﬁcient to non-deﬁcient levels. Thus, a comparison with our results is
diﬃcult. In a mere juxtaposition of recurrent costs, GR appears to be a sustainable
8 The $7 million for promotional activities in the supplementation programme include expenditures for
printing and distributing promotional leaﬂets, radio and TV broadcasts, and the cost of social mobiliza-
tion campaigns in urban and rural areas. Personnel costs account for over 70% of the total (Fiedler et al.,
2000).
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per year, while the annual cost of a hypothetical wheat ﬂour fortiﬁcation pro-
gramme was estimated at $4–6 million( Fiedler et al., 2000). However, this com-
parison should not be over-interpreted, because it neglects the beneﬁt side. Each
intervention has its advantages and shortcomings. Supplementation has a high eﬃ-
cacy, but especially inrural areas it is very costly. In dustrial fortiﬁcationis cheaper
but less favourable in terms of targeting the poor. GR could be complementary to
both. Although the technology’s eﬃcacy might be limited at present beta-carotene
contents, its coverage among the rural poor could potentially be high.
Sensitivity analysis
Although extensive eﬀorts have been made to derive realistic data and assump-
tions, many variables are still associated with uncertainty. Therefore, the sensitivity
of results is tested with respect to variations in key parameters. Individual values
are changed ceteris paribus, taking the original assumptions in the pessimistic and
optimistic scenarios as benchmarks. Table 6 shows the impacts onan n ual DALYs
gained and IRRs.
Table 5
Estimated cost of R&D and dissemination campaigns
Phase Cost (US$)
Adaptive research phase (3 years)
Infrastructure and operating expenditures 1,000,000
Personnel 423,000
Testing phase (3 years)
Infrastructure and operating expenditures 2,000,000
Personnel 300,000
Information and dissemination campaigns 7,000,000
Total cost up to ﬁrst technology release 10,723,000
Recurrent annual cost for maintenance research and monitoring 500,000
Table 6
Impact of parameter variations on results
Pessimistic scenario Optimistic scenario
DALYs gained IRR (%) DALYs gained IRR (%)
Original assumptions 15,311 66 85,137 133
Post-harvest losses: 50% 9801 51 49,423 110
Coverage rate: 25% 9569 50 35,474 97
Coverage rate: 100% 38,278 100 141,895 155
Amount of beta-carotene: 5 lg/g 49,720 110 115,773 146
Eﬃcacy function: linear 6356 37 44,693 106
Prevalence rates: half of present values 9766 51 54,836 114
R&D and dissemination costs: 150% 15,311 52 85,137 116
Technology depreciation: 5% per year 15,311
a 60 85,137
a 130
a It is assumed that these values decrease by 5% annually over the 10 year beneﬁt stream.
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instance, if GR will be stored or processed improperly, actually consumed
amounts of beta-carotene could be lower than initially assumed. Accordingly, the
technology’s eﬃcacy and health beneﬁts would shrink. Smaller beneﬁts could also
be due to lower coverage rates. Following researchers’ expectations, our initial
scenarios build on the assumption that GR technology would have little or no
impact onagricultural productivity or taste. However, acceptan ce problems
would arise if consumer characteristics turned out to be notably diﬀerent, or if
the transgenic varieties were agronomically inferior to conventional ones. This
underlines the importance of incorporating the technology into locally adapted
germplasm, including newly bred varieties with superior producer traits. Adop-
tion levels might also remain limited without appropriate information campaigns
during the early stages of diﬀusion. However, with suitable policies, it is also
possible that longer-term coverage rates are higher than initially assumed.
Besides, biotechnologists might manage to further increase the beta-carotene con-
tent in the grain. The advantage of the transgenic approach is that new genes
might be identiﬁed, which are more eﬃcient in micronutrient synthesis. The
results in Table 6 demonstrate that such developments would bring about notably
higher beneﬁts.
A diﬀerent source of uncertainty relates to the convexity of the eﬃcacy func-
tion. As was argued above, little is known about the exact parameterization, so
that inEq. (4), a fun ctionwith moderate curvature was speciﬁed. A lesser curva-
ture would lead to smaller positive health eﬀects and thus lower beneﬁts. In the
worst case, the eﬃcacy function would be linear, implying that a 1% reduction in
VA deﬁcit would lead to an equivalent change in eﬃcacy, regardless of the initial
VA status. Under this extreme assumption, the health beneﬁts would be less than
half the initial gains in the pessimistic, and slightly more than half in the optimis-
tic scenario.
Next, the inﬂuence of changing prevalence and mortality rates is analysed. In
2004, the Philippine wheat ﬂour fortiﬁcation programme, which was voluntary for
millers up till now, will become mandatory on a countrywide basis. This is before
GR will become available commercially. Given abovementioned targeting pro-
blems, not all deﬁcient people will be reached through wheat ﬂour fortiﬁcation.
Nonetheless, the programme is likely to reduce the prevalence of VAD up to a cer-
tain point. For illustrative purposes, we reduce the initial prevalence and mortality
rates by anexaggerated 50% for all three target groups. Inthat case, the health
costs without GR would only be half the previous value, and the technological
beneﬁts would be signiﬁcantly smaller too. Unsurprisingly, higher initial prevalence
rates or a bigger population, both of which are found in many other countries of
South and Southeast Asia, would have the opposite eﬀect (not shown). Because
GR varieties canbe reproduced by farmers, the cost of scalin g up their use will be
much smaller than for other micronutrient interventions.
Finally, the sensitivity is tested with respect to increases in project costs and a
possible reduction of beneﬁts over time. Cost increases could happen through
unexpected complications during R&D, testing and technology dissemination,
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9 Increasing
each individual cost item by 50% does not change the beneﬁt side, but the IRRs
are lower thanthose that were calculated with the origin al cost estimates. The
impact of anassumed 5% techn ology depreciationper year would be small, albeit
it would certainly challenge the technology’s sustainability. Overall, Table 6 re-
emphasises that the exact numerical outcomes of the scenario calculations should
be interpreted with caution. Nonetheless, even under fairly extreme parameter var-
iations, the health beneﬁts and IRRs remain sizeable. Many of the project details
can still be inﬂuenced by researchers and policymakers. Priorities should be set
towards maximizing the social returns.
Conclusions
VAD is a severe problem in developing countries, causing temporary and perma-
nent eye impairments and increased mortality, especially among children and preg-
nant and lactating women. The analysis shows that the annual health costs in the
Philippines are in a magnitude of 0.3% of the country’s GNP. These costs could be
reduced through GR. The scenario calculations demonstrate that GR will mitigate
problems of blindness and premature deaths, with social beneﬁts ranging between
$16 and 88 million per year.
Although these are remarkable gains, it must be clearly stated that GR alone
will not eliminate VAD and related health costs. Micronutrient deﬁciencies are
caused by a complex set of economic, social and cultural factors, so that a techno-
logical approach cannot be considered a magic bullet. The purpose of developing
GR is not to replace other interventions such as food fortiﬁcation, supplementa-
tionor dietary educationprogrammes. Rather, the techn ology should be seenas a
complementary tool in the ﬁght against VAD. GR is particularly promising for
remote rural areas, because, after the initial R&D investment, the cost and insti-
tutional eﬀort to reach the target population is much lower than for other interven-
tions. The advantage is that GR can be reproduced and multiplied by farmers
themselves. With appropriate information and dissemination campaigns during the
early stages of adoption, diﬀusion could potentially be fast and widespread
through anin formal exchan ge of seeds.
A preliminary cost–beneﬁt analysis shows that R&D expenditures for GR are a
highly proﬁtable public investment. In the scenario calculations, IRRs range
between 66% and 133%. These returns are higher than for many crop breeding
projects focusing on the improvement of agronomic traits. Of course, the beneﬁts
of agronomically improved crops and micronutrient-dense staple foods are diﬀer-
ent in nature. While the former show up in terms of increased real incomes for
agricultural producers and consumers, the latter consist primarily in a reduced
9 Technology depreciation could be the result of genetic dilution of the value-added trait. Although
rice is mostly self-pollinating, some dilution might occur when seeds are reproduced repeatedly.
Depreciation should be detained through regular supply of fresh material to informal seed markets.
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cular. These beneﬁts might be less visible, but our analysis demonstrates their high
economic signiﬁcance. The breeding approach appears to be a promising and
eﬃcient way of reducing micronutrient deﬁciencies among the poor.
However, it has to be emphasised that there is still a large degree of uncertainty
related to the technology’s eﬃcacy and coverage, which are key variables for the
scenario calculations. Although the sensitivity analysis conﬁrms the robustness of
the general statements, more research and better data are needed before far-reach-
ing conclusions can be drawn. Also, it should be pointed out that our analysis is
only a ﬁrst attempt to quantify the health impacts of micronutrient-enriched food
crops within an economic framework. There is ample scope for reﬁning and
extending the methodology employed. In particular, a further disaggregation of
target groups by income and/or region could deliver interesting results for
decision-making processes. With slight adjustments, the methodology could also
prove useful for the evaluation of crops containing other health-improving com-
pounds such as nutraceuticals or edible vaccines.
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